JP2024503723A5 - - Google Patents
Info
- Publication number
- JP2024503723A5 JP2024503723A5 JP2023543239A JP2023543239A JP2024503723A5 JP 2024503723 A5 JP2024503723 A5 JP 2024503723A5 JP 2023543239 A JP2023543239 A JP 2023543239A JP 2023543239 A JP2023543239 A JP 2023543239A JP 2024503723 A5 JP2024503723 A5 JP 2024503723A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- adenosine derivative
- derivative according
- composition according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163141450P | 2021-01-25 | 2021-01-25 | |
| US63/141,450 | 2021-01-25 | ||
| PCT/US2022/013660 WO2022159872A1 (en) | 2021-01-25 | 2022-01-25 | Adenosine derivative and pharmaceutical composition comprising the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024503723A JP2024503723A (ja) | 2024-01-26 |
| JP2024503723A5 true JP2024503723A5 (https=) | 2025-01-15 |
| JP7843289B2 JP7843289B2 (ja) | 2026-04-09 |
Family
ID=82494279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023543239A Active JP7843289B2 (ja) | 2021-01-25 | 2022-01-25 | アデノシン誘導体及びそれを含む医薬組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11793827B2 (https=) |
| EP (1) | EP4281081A4 (https=) |
| JP (1) | JP7843289B2 (https=) |
| KR (1) | KR20230132476A (https=) |
| CN (1) | CN116710465A (https=) |
| AU (1) | AU2022210781A1 (https=) |
| CA (1) | CA3202049A1 (https=) |
| IL (1) | IL304366A (https=) |
| MX (1) | MX2023008004A (https=) |
| TW (1) | TW202245805A (https=) |
| WO (1) | WO2022159872A1 (https=) |
| ZA (1) | ZA202408803B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3146679A1 (en) | 2019-07-27 | 2021-02-04 | Brii Biosciences, Inc. | Adenosine derivative and pharmaceutical composition comprising the same |
| EP4281081A4 (en) | 2021-01-25 | 2025-05-14 | Brii Biosciences, Inc. | ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF |
| EP4281083A4 (en) | 2021-01-25 | 2025-01-01 | Brii Biosciences, Inc. | COMBINATION THERAPY FOR HIV WITH ADENOSINE DERIVATIVE AND CAPSID INHIBITORS |
| CR20250310A (es) * | 2023-01-30 | 2025-08-25 | Merck Sharp & Dohme Llc | Profármacos de inhibidores de la transcriptasa inversa de nucleósidos sustituidos en 4' |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3407191A (en) * | 1966-08-29 | 1968-10-22 | Lilly Co Eli | Adamantoate esters of nucleosides |
| US5880154A (en) | 1994-02-01 | 1999-03-09 | The Board Of Regents Of The University Of Nebraska | Polymeric adamantane analogues |
| JP2007504232A (ja) | 2003-09-05 | 2007-03-01 | アナディス ファーマシューティカルズ インク | Ｃ型肝炎ウイルス感染治療用のｔｌｒ７リガンド及びそのプロドラッグの投与 |
| CA2502109C (en) | 2004-03-24 | 2010-02-23 | Yamasa Corporation | 4'-c-substituted-2-haloadenosine derivative |
| WO2007022073A2 (en) | 2005-08-12 | 2007-02-22 | Merck & Co., Inc. | Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives |
| WO2008011406A2 (en) | 2006-07-18 | 2008-01-24 | Anadys Pharmaceuticals, Inc. | Carbonate and carbamate prodrugs of thiazolo [4,5-d] pyrimidines |
| WO2011058582A1 (en) | 2009-11-16 | 2011-05-19 | Orchid Research Laboratories Ltd. | Histone deacetylase inhibitors for the treatment of fungal infections |
| WO2015143712A1 (en) | 2014-03-28 | 2015-10-01 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors |
| US9951141B2 (en) | 2014-06-02 | 2018-04-24 | Regeneron Pharmaceuticals, Inc. | Antibody-drug conjugates, their preparation and their therapeutic use |
| MX391226B (es) * | 2015-09-23 | 2025-03-21 | Merck Sharp & Dohme Llc | Inhibidores de transcriptasa inversa de nucleosido 4'-substituido y preparaciones de los mismos. |
| US20180030080A1 (en) * | 2016-07-28 | 2018-02-01 | Alexandre Vasilievich Ivachtchenko | Phosphoramidate nucleoside prodrug for treating viral diseases and cancer, processes for their preparation and their use |
| US10266558B2 (en) * | 2016-10-07 | 2019-04-23 | Alexandre Vasilievich Ivachtchenko | Macroheterocyclic nucleoside derivatives and their analogues, production and use thereof |
| RU2659388C1 (ru) * | 2017-02-28 | 2018-07-02 | Васильевич Иващенко Александр | Нуклеотиды, включающие N-[(S)-1-циклобутоксикарбонил]фосфорамидатный фрагмент, их аналоги и их применение |
| DK3590924T3 (da) | 2017-02-28 | 2022-01-03 | Kangpu Biopharmaceuticals Inc | Hidtil ukendt isoindolinderivat og farmaceutisk sammensætning og anvendelse deraf |
| US20190185508A1 (en) * | 2017-12-15 | 2019-06-20 | Merck Sharp & Dohme Corp. | Deuterated nucleoside reverse transcriptase inhibitors |
| EP3762396A1 (en) | 2018-03-07 | 2021-01-13 | GlaxoSmithKline Intellectual Property (No.2) Limited | Compounds useful in hiv therapy |
| CN109053803A (zh) | 2018-07-04 | 2018-12-21 | 米文君 | 一类新的化合物及其用途 |
| AU2019317810A1 (en) * | 2018-08-09 | 2021-02-25 | Glaxosmithkline Intellectual Property (No.2) Limited | Compounds useful in HIV therapy |
| JP2021536444A (ja) | 2018-08-30 | 2021-12-27 | グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited | Ｈｉｖ療法に有用な化合物 |
| CN113811360A (zh) | 2019-03-06 | 2021-12-17 | 葛兰素史密斯克莱知识产权（第2 号）有限公司 | 用于hiv治疗的化合物 |
| CA3146679A1 (en) | 2019-07-27 | 2021-02-04 | Brii Biosciences, Inc. | Adenosine derivative and pharmaceutical composition comprising the same |
| WO2021038509A1 (en) | 2019-08-28 | 2021-03-04 | Glaxosmithkline Intellectual Property (No.2) Limited | 4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy |
| KR20220066303A (ko) | 2019-09-11 | 2022-05-24 | 더 스크립스 리서치 인스티튜트 | 항바이러스 전구약물 및 이의 약제학적 조성물 |
| EP4281081A4 (en) | 2021-01-25 | 2025-05-14 | Brii Biosciences, Inc. | ADENOSINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF |
| EP4281083A4 (en) | 2021-01-25 | 2025-01-01 | Brii Biosciences, Inc. | COMBINATION THERAPY FOR HIV WITH ADENOSINE DERIVATIVE AND CAPSID INHIBITORS |
-
2022
- 2022-01-25 EP EP22743369.5A patent/EP4281081A4/en active Pending
- 2022-01-25 WO PCT/US2022/013660 patent/WO2022159872A1/en not_active Ceased
- 2022-01-25 JP JP2023543239A patent/JP7843289B2/ja active Active
- 2022-01-25 MX MX2023008004A patent/MX2023008004A/es unknown
- 2022-01-25 CA CA3202049A patent/CA3202049A1/en active Pending
- 2022-01-25 CN CN202280009277.3A patent/CN116710465A/zh active Pending
- 2022-01-25 KR KR1020237024605A patent/KR20230132476A/ko active Pending
- 2022-01-25 US US17/583,805 patent/US11793827B2/en active Active
- 2022-01-25 AU AU2022210781A patent/AU2022210781A1/en active Pending
- 2022-01-25 TW TW111103173A patent/TW202245805A/zh unknown
-
2023
- 2023-07-10 IL IL304366A patent/IL304366A/en unknown
- 2023-09-15 US US18/467,985 patent/US12390484B2/en active Active
-
2024
- 2024-11-20 ZA ZA2024/08803A patent/ZA202408803B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503723A5 (https=) | ||
| JP2022541667A5 (https=) | ||
| JP7719769B2 (ja) | 抗ウイルスプロドラッグ及びその医薬組成物 | |
| JP5140222B2 (ja) | 低用量エンテカビル製剤およびその使用 | |
| JP5027885B2 (ja) | 水難溶性カンプトテシン誘導体のサブミクロンナノ粒子及びその製造方法 | |
| JP3133345B2 (ja) | Ｈｉｖに対して活性な連結環状ポリアミン | |
| JP2991733B2 (ja) | 乾癬疾患を抑制するための薬剤及びその製法 | |
| JP6445591B2 (ja) | シロリムス及びその誘導体の複合体、それらの調製方法ならびにそれらを含有する医薬組成物 | |
| JP2002510329A (ja) | 親油性化合物用の自己乳化性処方 | |
| JP2007500229A5 (https=) | ||
| JP2021521222A (ja) | ６，８−ビス−ベンジルチオ−オクタン酸を使用して前立腺癌を治療するための治療方法および組成物 | |
| JP2006070032A (ja) | 抗血管形成薬剤組成物 | |
| US20220054445A1 (en) | Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor | |
| RU2358730C2 (ru) | Производное эпотилона для лечения гепатомы и других раковых заболеваний | |
| AU2021284155A1 (en) | Compositions, their uses in therapy and methods thereof | |
| JP2022521119A5 (https=) | ||
| JP2009504746A (ja) | 第Ｘａ因子インヒビターのシクロデキストリン包接複合体 | |
| CN104080449A (zh) | 4，9-二羟基-萘并[2，3-b]呋喃脂肪酸酯衍生物的纳米颗粒水悬液的制备方法 | |
| CA3121929A1 (en) | Therapeutic methods and compositions for treating cancer using 6,8-bis-benzylthio-octanoic acid and an autophagy inhibitor | |
| JP4090133B2 (ja) | 抗マラリア剤 | |
| CN105163732A (zh) | 用于治疗眼科疾病和病症的方法 | |
| JPH10503178A (ja) | Ｈｉｖ感染のための組合わせ療法 | |
| WO2014015153A2 (en) | Compositions and methods for treating ewing's sarcoma and other disorders related to ews-fli1 | |
| JP2013529686A5 (https=) | ||
| RU2022104985A (ru) | Аденозиновое производное и фармацевтическая композиция, содержащая его |